UK markets close in 4 hours 11 minutes

Xvivo Perfusion AB (publ) (XVIVOS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
320.750.00 (0.00%)
As of 08:56AM BST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
29,882
91,820
18,427
8,152
-43,735
-
Depreciation & amortisation
-
76,350
42,167
32,257
30,038
-
Stock-based compensation
-
2,302
0
-
-
-
Change in working capital
-30,421
-39,224
-22,167
-23,218
-4,500
-
Inventory
3,313
-33,481
-6,325
-13,802
-14,155
-
Other working capital
-88,569
-97,649
-103,090
-106,133
-76,943
-
Other non-cash items
-
-
-
-20,290
6,641
2,678
Net cash provided by operating activities
5,505
46,287
27,856
-12,059
-12,266
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-143,936
-130,946
-94,074
-64,677
-
Acquisitions, net
-
-17,680
-67,447
-93,228
-201,319
-
Purchases of investments
-
-
-
-401
-536
-151
Sales/maturities of investments
-
-
769
-
-
-
Net cash used for investing activities
-245,728
-161,619
-197,624
-187,703
-266,532
-
Net change in cash
-7,370
303,215
-176,610
34,849
203,970
-
Cash at beginning of period
284,516
246,545
398,696
354,236
159,946
-
Cash at end of period
277,146
546,088
246,545
398,696
354,236
-
Free cash flow
Operating cash flow
5,505
46,287
27,856
-12,059
-12,266
-
Capital expenditure
-
-143,936
-130,946
-94,074
-64,677
-
Free cash flow
-88,569
-97,649
-103,090
-106,133
-76,943
-